GlassScriptPhysician profile
Randall A Scott
NPI 1528069267
$1,912.02
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $127 · 2021: $535 · 2022: $702 · 2023: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $548.30 | 2019-2023 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $326.31 | 2020-2023 | |
| Neurocrine Biosciences, INC. | $243.54 | 2021-2023 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $176.27 | 2019-2023 | Abilify Maintena |
| Vanda Pharmaceuticals INC. | $139.12 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $136.11 | 2019-2023 | Trintellix |
| Sunovion Pharmaceuticals INC. | $105.47 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $89.95 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $46.79 | 2023 | Austedo Xr |
| Corium, LLC | $41.36 | 2022-2023 | Azstarys |
| Eisai INC. | $17.60 | 2021 | |
| Merck Sharp & Dohme LLC | $15.43 | 2022 | |
| Lundbeck LLC | $14.58 | 2019 | |
| Novo Nordisk INC | $11.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.